Back to the feed
In brief
On 02.09.2026, a person holding the function "Executive member of the board of directors / senior management" at Basilea Pharmaceutica AG, Allschwil disclosed a sale worth CHF 212’360 to SIX Exchange Regulation.
This is the largest management sale disclosed at Basilea Pharmaceutica AG, Allschwil over the previous 12 months (20 sales in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Basilea Pharmaceutica AG, Allschwil declared a "Sale" transaction on 02.09.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date02.09.2026
Issuing companyBasilea Pharmaceutica AG, Allschwil
ISINCH0011432447
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity3’273
Unit priceCHF 64.88
AmountCHF 212’360
ExchangeXSWX
Notification IDT1Q9200023
Other Basilea Pharmaceutica AG, Allschwil insider transactions
- Sale · Executive member of the board of directors / senior management01.10.2026CHF 61’034
- Sale · Executive member of the board of directors / senior management21.09.2026CHF 43’184
- Sale · Executive member of the board of directors / senior management21.09.2026CHF 20’858
- Sale · Executive member of the board of directors / senior management16.09.2026CHF 13’380
- Sale · Executive member of the board of directors / senior management15.09.2026CHF 19’770
These figures aggregate public disclosures. They are not investment advice.